Current recommendations for the treatment of hepatic encephalopathy are based, to a large extent, on open or uncontrolled trials, undertaken in very small numbers of patients. In consequence, there is ongoing discussion as to whether the classical approach to the treatment of this condition, which aims at reducing ammonia production and absorption using either non-absorbable disaccharides and/ or antibiotics, should be revisited, modified or even abandoned. Pros and cons of present therapeutic strategies and possible future developments were discussed at the fourth International Hannover Conference on Hepatic Encephalopathy held in Dresden in June 2006. The content of this discussion is summarized.
Treatment of hepatic encephalopathy / M.Y. Morgan; R. Jalan; G. Kircheis; W. Fleig; O. Riggio; G. Marchesini Reggiani; K. Grungreiff; A. Blei; K. Weissenborn. - In: METABOLIC BRAIN DISEASE. - ISSN 0885-7490. - STAMPA. - 22:(2007), pp. 389-405. (Intervento presentato al convegno 4th International Hannover Conference on Hepatic Encephalopathy tenutosi a Dresden, Germany nel 10-13 Giugno 2006).
Treatment of hepatic encephalopathy
MARCHESINI REGGIANI, GIULIO;
2007
Abstract
Current recommendations for the treatment of hepatic encephalopathy are based, to a large extent, on open or uncontrolled trials, undertaken in very small numbers of patients. In consequence, there is ongoing discussion as to whether the classical approach to the treatment of this condition, which aims at reducing ammonia production and absorption using either non-absorbable disaccharides and/ or antibiotics, should be revisited, modified or even abandoned. Pros and cons of present therapeutic strategies and possible future developments were discussed at the fourth International Hannover Conference on Hepatic Encephalopathy held in Dresden in June 2006. The content of this discussion is summarized.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
